Foghorn Therapeutics Newsroom

H.C. Wainwright Maintains Foghorn Therapeutics(FHTX.US) With Buy Rating, Cuts Target Price to $13

Futu NewsDec 17 19:31

Morgan Stanley Maintains Foghorn Therapeutics(FHTX.US) With Hold Rating, Maintains Target Price $9

Futu NewsDec 17 09:31

Foghorn Therapeutics: Hold Rating Amid Strategic Pivot and Uncertainty in Drug Development

TipRanksDec 17 08:57

Foghorn Therapeutics Is Maintained at Buy by Jefferies

Dow JonesDec 17 03:18

Foghorn Therapeutics Analyst Ratings

BenzingaDec 17 03:09

Wedbush Cuts Price Target on Foghorn Therapeutics to $10 From $13, Keeps Outperform Rating

MT NewswiresDec 17 00:06

Jefferies Maintains Foghorn Therapeutics(FHTX.US) With Buy Rating, Cuts Target Price to $14

Futu NewsDec 16 22:31

Analysts Conflicted on These Healthcare Names: Solid Biosciences (SLDB), Foghorn Therapeutics (FHTX) and KalVista Pharmaceuticals (KALV)

TipRanksDec 6 02:33

TD Cowen Maintains Foghorn Therapeutics(FHTX.US) With Buy Rating

Futu NewsNov 5 21:35

H.C. Wainwright Maintains Foghorn Therapeutics(FHTX.US) With Buy Rating, Maintains Target Price $20

Futu NewsNov 5 19:36

TD Cowen Maintains Foghorn Therapeutics(FHTX.US) With Buy Rating

Futu NewsNov 5 08:33

TD Cowen Keeps Their Buy Rating on Foghorn Therapeutics (FHTX)

TipRanksNov 5 08:19

Foghorn Therapeutics Analyst Ratings

BenzingaSep 24 19:30

Morgan Stanley Adjusts Foghorn Therapeutics Price Target to $9 From $6, Maintains Equalweight Rating

MT NewswiresSep 23 21:45

Jefferies Initiates Foghorn Therapeutics(FHTX.US) With Buy Rating, Announces Target Price $18

Futu NewsSep 3 17:32

Foghorn Therapeutics Analyst Ratings

BenzingaAug 19 21:57

Evercore ISI Group Initiates Coverage On Foghorn Therapeutics With Outperform Rating, Announces Price Target of $20

BenzingaAug 19 21:57

Evercore Maintains Foghorn Therapeutics(FHTX.US) With Buy Rating, Maintains Target Price $20

Futu NewsAug 19 20:31

Analysts Offer Insights on Healthcare Companies: Equillium (EQ), Foghorn Therapeutics (FHTX) and Immix Biopharma, Inc. (IMMX)

TipRanksAug 19 18:42

Evercore Initiates Foghorn Therapeutics(FHTX.US) With Buy Rating, Announces Target Price $20

Futu NewsAug 19 18:31